FDA offers guidelines on device ID rule, de novo review process

08/15/2014 | MassDevice.com (Boston)

The FDA has released its final guidelines on how small firms may satisfy the unique device identifier rules, including information related to the appearance of UDIs, rule exceptions and record-keeping standards. The agency also issued a draft document meant to guide companies when submitting Class III medical devices under the agency's de novo review program.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD